Related Experiment Video
Updated: Aug 22, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
(S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(--)-methadone
Mark R Hutchinson1, Andrew A Somogyi
1Department of Clinical and Experimental Pharmacology, University of Adelaide, Level 5, Medical School North, Frome Road, 5005, Adelaide, Australia. mark.hutchinson@adelaide.edu.au
Abstract:
Methadone is a widely used synthetic opioid which is administered as a racemic mixture of (R)-(--)- and (S)-(+)-enantiomers, with only (R)-(--)-methadone possessing mu opioid receptor agonist activity. Methadone inhibits numerous immune functions in vitro at concentrations above 10 microM in a nonstereoselective and naloxone-insensitive fashion, suggesting the presence of nonclassical opioid receptors on immune cells. No in vivo data on the effects of methadone's enantiomers on immune function are available. Therefore, the stereoselectivity of methadone's analgesia (hot plate latency) in vivo and immune suppression ex vivo (splenocyte proliferation) was investigated in groups of Balb/c mice. Significant analgesia was observed in animals that received racemic methadone (P=0.0012, 52% MPE) and (R)-(--)-methadone (P=0.0002, 70% MPE) when compared to saline-treated controls, while (S)-(+)-methadone was devoid of any such effect (-4% MPE). In vivo (R)-(--)- and racemic methadone caused significant inhibition (P<0.001, greater than -70%) of basal proliferation compared to saline control. In stark contrast to analgesia, in vivo (S)-(+)-methadone caused significantly greater inhibition of basal proliferation (P<0.001, -130%) than (R)-(--)- and racemic methadone. The immune suppression caused by methadone is not purely a classical opioid response but involves nonclassical opioid receptors located at the central level, which have yet to be characterised. Moreover, the dose at which immune suppression occurred could be achieved clinically.
Insights
This study reveals that while (R)-methadone provides pain relief, both (R)- and (S)-methadone enantiomers suppress immune cell proliferation in vivo, suggesting nonclassical opioid receptor involvement.
Area of Science:
- Pharmacology
- Immunology
- Neuroscience
Background:
- Methadone, a synthetic opioid, is administered as a racemic mixture.
- Only the (R)-(--)-methadone enantiomer exhibits mu opioid receptor agonist activity.
- In vitro studies suggest methadone affects immune function via nonclassical opioid receptors.
Purpose of the Study:
- To investigate the stereoselectivity of methadone's analgesic and immunomodulatory effects in vivo.
- To compare the in vivo effects of (R)-(--)-methadone, (S)-(+)-methadone, and racemic methadone on analgesia and splenocyte proliferation.
Main Methods:
- Assessment of analgesia using the hot plate test in Balb/c mice.
- Ex vivo evaluation of splenocyte proliferation following in vivo administration of methadone enantiomers.
- Statistical analysis to determine the significance of observed effects compared to saline controls.
Main Results:
- Significant analgesia was observed with racemic and (R)-(--)-methadone, but not with (S)-(+)-methadone.
- Both (R)-(--)- and racemic methadone significantly inhibited basal splenocyte proliferation in vivo.
- Unexpectedly, (S)-(+)-methadone induced a greater inhibition of splenocyte proliferation than (R)-(--)- and racemic methadone.
Conclusions:
- Methadone's immune suppression in vivo is not solely mediated by classical opioid receptors.
- Nonclassical opioid receptors, potentially at the central level, are implicated in methadone's immunomodulatory effects.
- The observed immune suppression occurs at clinically achievable methadone doses.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Opioid Receptors: Overview